Skip to Content

A Randomized Phase III Trial of Lenalidomide vs. Observation Alone in High-Risk Myeloma

Objective
ECOG E3A06 A Randomized Phase III Trial of Lenalidomide vs. Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma

Myeloma: The purpose of this study is to find out what effects (good and bad) the use of the drug lenalidomide has on patients and their multiple myeloma, and to compare this with patients that receive no therapy.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

Rutland Regional Medical Center
160 Allen Street
Rutland, VT 05701
802.775.7111

Facebook YouTube LinkedIn Twitter